The effect of greeen tea, capsaicin and ginger extracts on obesity

The effect of capsule containing greeen tea, capsaicin and ginger extracts on weight of obese peoples

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015122712438N15

Enrollment

Registered

2016-01-05

Start date

2016-01-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity and over weight. Obesity

Interventions

Intervention 1: Intervention:herbal capsule manufactured by Barij essence pharmaceutical company,Twice a day, each time two. for 8 weeks. Intervention 2: control:placebo capsule manufactured by Barij

Treatment - Drugs

Placebo

Intervention:herbal capsule manufactured by Barij essence pharmaceutical company,Twice a day, each time two. for 8 weeks

control:placebo capsule manufactured by Barij essence pharmaceutical company,Twice a day, each time two. for 8 weeks

Eligibility

Sex/Gender

Male

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:18-50 years old.BMI>25 exclusion criteria: metabolic disorders; nutritional supplements; pregnancy; lactation; thyroid and parathyroid disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Weight. Timepoint: Baseline and End-of-trial. Method of measurement: scale.;Metabolic profile. Timepoint: Baseline and End-of-trial. Method of measurement: blood sample.;ALT,AST? ALK. Timepoint: Baseline and End-of-trial. Method of measurement: blood sample.;TAC. Timepoint: Baseline and End-of-trial. Method of measurement: blood sample.;Thyroid hormones. Timepoint: Baseline and End-of-trial. Method of measurement: blood sample.	—

Measure

Time frame

Weight. Timepoint: Baseline and End-of-trial. Method of measurement: scale.;Metabolic profile. Timepoint: Baseline and End-of-trial. Method of measurement: blood sample.;ALT,AST? ALK. Timepoint: Baseline and End-of-trial. Method of measurement: blood sample.;TAC. Timepoint: Baseline and End-of-trial. Method of measurement: blood sample.;Thyroid hormones. Timepoint: Baseline and End-of-trial. Method of measurement: blood sample.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Taghizadeh

Kashan University of Medical Sciences

mohsenta44@yahoo.com taghizadeh_m@kaums.ac.ir+98 31 5554 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026